REVIEW OF IMMUNOSUPPRESSION FOR LUNG TRANSPLANTATION

This publication has 83 references indexed in Scilit:

• Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide
  Current Opinion in Immunology, 1996
• EFFECTS OF LEFLUNOMIDE AND OTHER IMMUNOSUPPRESSIVE AGENTS ON T CELL PROLIFERATION IN VITRO1
  Transplantation, 1996
• Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection
  The Lancet, 1995
• EFFECTS OF RAPAMYCIN ON GROWTH FACTOR-STIMULATED VASCULAR SMOOTH MUSCLE CELL DNA SYNTHESIS INHIBITION OF BASIC FIBROBLAST GROWTH FACTOR AND PLATELET-DERIVED GROWTH FACTOR ACTION AND ANTAGONISM OF RAPAMYCIN BY FK506
  Transplantation, 1995
• EFFECTS OF RS61443 ON FUNCTIONAL AND MORPHOLOGICAL CHANGES IN CHRONICALLY REJECTING RAT KIDNEY ALLOGRAFTS1,2
  Transplantation, 1995
• Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection
  The Lancet, 1994
• PROLONGATION OF CANINE INTESTINAL ALLOGRAFT SURVIVAL WITH RS-61443, CYCLOSPORINE, AND PREDNISONE
  Transplantation, 1993
• Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection
  Inflammation Research, 1991
• RAPAMYCIN FOR IMMUNOSUPPRESSION IN ORGAN ALLOGRAFTING
  The Lancet, 1989
• Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity — I. Disease modifying action on adjuvant arthritis of the rat
  International Journal of Immunopharmacology, 1985